| Revenue growth | -16% YoY for FY26; Q4FY26 -12% YoY. |
|---|---|
| Margins | FY26 EBITDA margin at 25%, meeting guidance despite top-line pressure. |
| Order book | Continues to support growth outlook for FY27. |
| Demand visibility | Strong order book; cautious optimism for H2FY27. |
| Management confidence | Positive for FY27 growth despite cyclical volatility. |
Growth
FY26 Revenue fell 16%, EBITDA dropped 22%, and PAT decreased 20%. Q4FY26 revenue saw a 12% decline YoY.
Outlook
Positive FY27 outlook with 5+ new molecules for launch; FY26 capex was ₹11,508 Mn; Pharma revenue grew 40%.
Risks
Global agrochemical industry contraction, lower crop prices, adverse weather, and elevated market inventory levels in the domestic segment.
Earnings Call filed with NSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹2,205.80
- Market cap
- ₹33,466 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 28.7×Sector 37.2×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Other Announcement
Designated person Jayesh Dholariya disclosed the sale of 3,000 equity shares via gift, totaling approximately Rs. 0.75 Crore.
- Value
- ₹0.75 Cr
PI Industries Annual General Meeting
PI Industries held its 79th Annual General Meeting on August 14, 2026. Shareholders approved all nine agenda items, including financial statements and dividend payments.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Investor Presentation: Key Takeaways
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.